Log in to save to my catalogue

Radiopharmaceuticals heat anti-tumor immunity

Radiopharmaceuticals heat anti-tumor immunity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9830438

Radiopharmaceuticals heat anti-tumor immunity

About this item

Full title

Radiopharmaceuticals heat anti-tumor immunity

Publisher

Australia: Ivyspring International Publisher Pty Ltd

Journal title

Theranostics, 2023, Vol.13 (2), p.767-786

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher Pty Ltd

More information

Scope and Contents

Contents

Radiopharmaceutical therapy (RPT) has proven to be an effective cancer treatment with minimal toxicity. With several RPT agents approved by FDA, the remarkable potential of this therapy is now being recognized, and the anti-tumor immunity induced by RPT is beginning to be noticed. This review evaluates the potential of RPT for immune activation, in...

Alternative Titles

Full title

Radiopharmaceuticals heat anti-tumor immunity

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9830438

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9830438

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.79806

How to access this item